| Quarter (USD) | Sep 24 | Jun 24 | Mar 24 | Dec 23 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
|---|---|---|---|---|---|---|
| Cash on hand (at last report) | 410.88 mm | 410.88 mm | 410.88 mm | 410.88 mm | 410.88 mm | 410.88 mm |
| Cash burn (monthly) | (no burn) | (no burn) | 9.82 mm | 3.05 mm | (no burn) | 434.08 k |
| Cash used (since last report) | n/a | n/a | 49.89 mm | 15.52 mm | n/a | 2.21 mm |
| Cash remaining | n/a | n/a | 360.99 mm | 395.36 mm | n/a | 408.67 mm |
| Runway (months of cash) | n/a | n/a | 36.8 | 129.5 | n/a | 941.5 |
| 13F holders | Current |
|---|---|
| Total holders | 66 |
| Opened positions | 46 |
| Closed positions | 3 |
| Increased positions | 10 |
| Reduced positions | 5 |
| 13F shares | Current |
|---|---|
| Total value | 579.47 bn |
| Total shares | 31.04 mm |
| Total puts | 0.00 |
| Total calls | 0.00 |
| Total put/call ratio | – |
| Largest owners | Shares | Value |
|---|---|---|
| FMR | 5.51 mm | $106.88 bn |
| Fairmount Funds Management | 3.37 mm | $65.38 bn |
| VR Adviser | 3.29 mm | $63.71 bn |
| RTW Investments | 1.95 mm | $37.73 bn |
| Vanguard | 1.61 mm | $31.23 bn |
| Commodore Capital | 1.42 mm | $27.53 bn |
| T. Rowe Price | 1.33 mm | $25.73 mm |
| Braidwell | 1.15 mm | $27.10 bn |
| JHG Janus Henderson | 849.41 k | $16.41 bn |
| Perceptive Advisors | 845.57 k | $16.40 bn |
| Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 14 Feb 25 | Venrock Healthcare Capital Partners III | Common Stock | Buy | Acquire P | Yes | No | 11.44 | 88,794 | 1.02 mm | 4,148,428 |
| 13 Feb 25 | Venrock Healthcare Capital Partners III | Common Stock | Buy | Acquire P | Yes | No | 11.63 | 14,950 | 173.87 k | 4,059,634 |
| 12 Feb 25 | Venrock Healthcare Capital Partners III | Common Stock | Buy | Acquire P | Yes | No | 11.86 | 8,971 | 106.40 k | 4,044,684 |
| 11 Feb 25 | Venrock Healthcare Capital Partners III | Common Stock | Buy | Acquire P | Yes | No | 10.95 | 9,593 | 105.04 k | 4,035,713 |
| 10 Feb 25 | Venrock Healthcare Capital Partners III | Common Stock | Buy | Acquire P | Yes | No | 10.9 | 574 | 6.26 k | 4,026,120 |
| 22 Jan 25 | Klein Lawrence Otto | Employee Stock Option Common Stock | Grant | Acquire A | No | No | 12.5 | 230,000 | 2.88 mm | 230,000 |
| 22 Jan 25 | Goncalves Joana | Employee Stock Option Common Stock | Grant | Acquire A | No | No | 12.5 | 162,500 | 2.03 mm | 162,500 |
| 22 Jan 25 | Paul T Quinlan | Employee Stock Option Common Stock | Grant | Acquire A | No | No | 12.5 | 162,500 | 2.03 mm | 162,500 |
